Owners, management and financials
CVR: 43803999
DKK 925,944
Gross profit
Net result: DKK -3,335,844
Alpha Healthcare Investments ApS (25-33,32%), Dare to Dream ApS (33,33-49,99%)
1 more
CVR · view owners
Thomas Kirkegaard Jensen
Board: Anders Mørkeberg Hinsby (chair) and 2 members
CVR · view management
Active
Founded 23 January 2023
CVR · view overview
5 employees
Annual report 2025 · average
Director registered: Thomas Kirkegaard Jensen
CVR · 23/01/2023
View the full event history
Amplify Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Thomas Kirkegaard Jensen. The board consists of Anders Mørkeberg Hinsby (chair), Anders Vadsholt and Thomas Kirkegaard Jensen. The company is owned by Alpha Healthcare Investments ApS, Dare to Dream ApS and WoB Holding ApS. According to the 2025 annual report, the company had an average of 5 employees. In 2025, the company reported a gross profit of DKK 925,944 and a net result of DKK -3,335,844 compared with DKK -7,194,854 the year before. Equity in the 2025 report amounted to DKK -12,443,417.
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 926 t. | -3.3 mio. | 3.4 mio. | -12.4 mio. | 5 | |
| 202401/01/2024 – 31/12/2024 | -5 mio. | -7.2 mio. | 5.9 mio. | -9.1 mio. | 3 | |
| 202323/01/2023 – 31/12/2023 | -1.6 mio. | -2 mio. | 2.6 mio. | -1.9 mio. | 1 |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Amplify Therapeutics ApS is 43803999.
Amplify Therapeutics ApS is owned by Alpha Healthcare Investments ApS, Dare to Dream ApS and WoB Holding ApS.
The management of Amplify Therapeutics ApS consists of Thomas Kirkegaard Jensen.
The board of Amplify Therapeutics ApS consists of Anders Mørkeberg Hinsby, Anders Vadsholt and Thomas Kirkegaard Jensen, with Anders Mørkeberg Hinsby as chair.
In 2025, Amplify Therapeutics ApS reported a gross profit of DKK 925,944.
Amplify Therapeutics ApS had an average of 5 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
Amplify Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK 925,944, and the net result was DKK -3,335,844.
Amplify Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -4,961,503, and the net result was DKK -7,194,854.
Amplify Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -1,558,702, and the net result was DKK -1,952,719.
As of January 23, 2023, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Amplify Therapeutics ApS.
As of January 23, 2023, Anders Vadsholt has joined the board of directors of Amplify Therapeutics ApS.
As of January 23, 2023, Thomas Kirkegaard Jensen has joined the board of directors of Amplify Therapeutics ApS.
As of January 23, 2023, Anders Mørkeberg Hinsby has joined the board of directors of Amplify Therapeutics ApS.
As of January 23, 2023, Thomas Kirkegaard Jensen is registered as director of Amplify Therapeutics ApS.
As of January 23, 2023, Alpha Healthcare Investments ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 25%.
As of January 23, 2023, Dare to Dream ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 33%.
As of January 23, 2023, WoB Holding ApS is registered as an owner of Amplify Therapeutics ApS with an ownership share of 25%.
Amplify Therapeutics ApS was founded on January 23, 2023.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583
